VOSEVI (400 mg sofosbuvir, 100 mg velpatasvir, and 100 mg)

VOSEVI

VOSEVI

Sofosbuvir, Velpatasvir, and Voxilaprevir

400mg/100mg

Gilead Sciences

Medical Use

VOSEVI is a prescription medication for adults with chronic hepatitis C virus (HCV) infection, either without cirrhosis or with compensated cirrhosis. It is used in the following cases:

  • -Patients with genotype 1, 2, 3, 4, 5, or 6 who have previously been treated with an HCV regimen that included an NS5A inhibitor.
  • -Patients with genotype 1a or 3 who have previously been treated with an HCV regimen that included sofosbuvir but not an NS5A inhibitor.

The safety and effectiveness of VOSEVI in children have not been established.